6622 — Zhaoke Ophthalmology Cashflow Statement
0.000.00%
Last trade - 00:00- HK$1.60bn
- HK$839.97m
- CNY31.97m
Annual cashflow statement for Zhaoke Ophthalmology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -2,130 | -407 | -384 | -237 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 1,856 | 40.5 | -46.7 | -28.1 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.91 | 0.646 | 58.8 | -41.7 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -245 | -331 | -324 | -254 | — |
| Capital Expenditures | -79.4 | -239 | -95.3 | -44.1 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 763 | -86 | 19.5 | -72.4 | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 684 | -325 | -75.8 | -116 | — |
| Financing Cash Flow Items | -81 | -3.14 | -5.88 | -9.78 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,659 | 76.2 | 99.3 | -12.1 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2,063 | -412 | -255 | -341 | — |